Cell Isolation Market - 2012-2030
The Cell Isolation Market was valued at 6.67 million in 2012 and is anticipated to reach by 2030, at a CAGR of 0.172 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Cell Isolation Market.
This report delivers a comprehensive overview of the Cell Isolation Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Isolation Market. The Cell Isolation Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2012–2030.
Cell Isolation Market Scope:
Key Players
This report delivers a comprehensive overview of the Cell Isolation Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Isolation Market. The Cell Isolation Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2012–2030.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Cell Isolation Market.
This report delivers a comprehensive overview of the Cell Isolation Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Isolation Market. The Cell Isolation Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2012–2030.
Cell Isolation Market Scope:
Key Players
- Becton Dickinson and Company
- Beckman Coulter, Inc
- GE Healthcare
- Merck KgaA
- Miltenyi Biotec
- Thermo Fisher Scientific
- Bio-Rad Laboratories Inc
- Terumo BCT
- PluriSelect Life Science UG & Co. KG
- STEMCELL Technologies Inc
This report delivers a comprehensive overview of the Cell Isolation Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Isolation Market. The Cell Isolation Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2012–2030.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Cell Type
3.2. Market snippet by Cell Source
3.3. Market snippet by Product
3.4. Market snippet by Technique
3.5. Market snippet by Application
3.6. Market Snippet by End-User
3.7. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Chronic Diseases
4.1.1.2. Technological Advancement in Cell Isolation
4.1.1.3. XX
4.1.2. Restraints:
4.1.2.1. Strict Regulations and Compliances for Cell Separation
4.1.2.2. XX
4.2. Opportunity
4.3. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. COVID-19 Impact Analysis
6. BY CELL TYPE
6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type Segment
6.3. Market Attractiveness Index, By Cell Type Segment
6.3.1. Animal Cells*
6.3.1.1. Introduction
6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
6.3.2. Human Cells
6.3.2.1. Stem Cells
6.3.2.2. Differentiated Cells
7. BY CELL SOURCE
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source Shape
7.3. Market Attractiveness Index, By Cell Source Segment
7.3.1. Bone Marrow*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. Adipose Tissue
7.3.3. Cord Blood/Embryonic Stem Cells
8. BY TECHNIQUE
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique Segment
8.3. Market Attractiveness Index, By Technique Segment
8.3.1. Surface Marker-Based Cell Isolation*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Centrifugation-Based Cell Isolation
8.3.3. Filtration-Based Cell Isolation
9. BY PRODUCT
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
9.3. Market Attractiveness Index, By Product Segment
9.3.1. Consumables*
9.3.1.1.1. Introduction
9.3.1.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.3.1.2. Reagents & kits
9.3.1.3. Disposables
9.3.1.4. Beads
9.3.2. Instruments
9.3.2.1. Flow cytometers
9.3.2.2. Centrifuges
9.3.2.3. Magnetic-activated cell separator systems
9.3.2.4. Filtration systems
10. BY APPLICATION
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
10.3. Market Attractiveness Index, By Application Segment
10.3.1. Cancer Research*
10.3.1.1. Introduction
10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
10.3.2. Stem Cell Research
10.3.3. In Vitro Diagnostics
10.3.4. Biomolecule Isolation
10.3.5. Tissue Regeneration
10.3.6. Others
11. BY END-USER
11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
11.3. Market Attractiveness Index, By End-User Segment
11.3.1. Hospitals and Diagnostic Laboratories*
11.3.1.1. Introduction
11.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
11.3.2. Research Laboratories and Institutes
11.3.3. Biotechnology and Biopharmaceutical Companies
11.3.4. Cell Banks
11.3.5. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
12.2.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.2.9.1. The U.S.
12.2.9.2. Canada
12.2.9.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
12.3.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.3.9.1. Germany
12.3.9.2. The U.K.
12.3.9.3. France
12.3.9.4. Italy
12.3.9.5. Spain
12.3.9.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
12.4.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.4.9.1. Brazil
12.4.9.2. Argentina
12.4.9.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
12.5.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.5.9.1. China
12.5.9.2. India
12.5.9.3. Japan
12.5.9.4. Australia
12.5.9.5. Rest of Asia Pacific
12.6. The Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Becton Dickinson and Company*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. Beckman Coulter, Inc
14.3. GE Healthcare
14.4. Merck KgaA
14.5. Miltenyi Biotec
14.6. Thermo Fisher Scientific
14.7. Bio-Rad Laboratories Inc
14.8. Terumo BCT
14.9. PluriSelect Life Science UG & Co. KG
14.10. STEMCELL Technologies Inc (LIST NOT EXHAUSTIVE)
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Cell Type
3.2. Market snippet by Cell Source
3.3. Market snippet by Product
3.4. Market snippet by Technique
3.5. Market snippet by Application
3.6. Market Snippet by End-User
3.7. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Chronic Diseases
4.1.1.2. Technological Advancement in Cell Isolation
4.1.1.3. XX
4.1.2. Restraints:
4.1.2.1. Strict Regulations and Compliances for Cell Separation
4.1.2.2. XX
4.2. Opportunity
4.3. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. COVID-19 Impact Analysis
6. BY CELL TYPE
6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type Segment
6.3. Market Attractiveness Index, By Cell Type Segment
6.3.1. Animal Cells*
6.3.1.1. Introduction
6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
6.3.2. Human Cells
6.3.2.1. Stem Cells
6.3.2.2. Differentiated Cells
7. BY CELL SOURCE
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source Shape
7.3. Market Attractiveness Index, By Cell Source Segment
7.3.1. Bone Marrow*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. Adipose Tissue
7.3.3. Cord Blood/Embryonic Stem Cells
8. BY TECHNIQUE
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique Segment
8.3. Market Attractiveness Index, By Technique Segment
8.3.1. Surface Marker-Based Cell Isolation*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Centrifugation-Based Cell Isolation
8.3.3. Filtration-Based Cell Isolation
9. BY PRODUCT
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
9.3. Market Attractiveness Index, By Product Segment
9.3.1. Consumables*
9.3.1.1.1. Introduction
9.3.1.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.3.1.2. Reagents & kits
9.3.1.3. Disposables
9.3.1.4. Beads
9.3.2. Instruments
9.3.2.1. Flow cytometers
9.3.2.2. Centrifuges
9.3.2.3. Magnetic-activated cell separator systems
9.3.2.4. Filtration systems
10. BY APPLICATION
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
10.3. Market Attractiveness Index, By Application Segment
10.3.1. Cancer Research*
10.3.1.1. Introduction
10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
10.3.2. Stem Cell Research
10.3.3. In Vitro Diagnostics
10.3.4. Biomolecule Isolation
10.3.5. Tissue Regeneration
10.3.6. Others
11. BY END-USER
11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
11.3. Market Attractiveness Index, By End-User Segment
11.3.1. Hospitals and Diagnostic Laboratories*
11.3.1.1. Introduction
11.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
11.3.2. Research Laboratories and Institutes
11.3.3. Biotechnology and Biopharmaceutical Companies
11.3.4. Cell Banks
11.3.5. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
12.2.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.2.9.1. The U.S.
12.2.9.2. Canada
12.2.9.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
12.3.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.3.9.1. Germany
12.3.9.2. The U.K.
12.3.9.3. France
12.3.9.4. Italy
12.3.9.5. Spain
12.3.9.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
12.4.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.4.9.1. Brazil
12.4.9.2. Argentina
12.4.9.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
12.5.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.5.9.1. China
12.5.9.2. India
12.5.9.3. Japan
12.5.9.4. Australia
12.5.9.5. Rest of Asia Pacific
12.6. The Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Type
12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Source
12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Becton Dickinson and Company*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. Beckman Coulter, Inc
14.3. GE Healthcare
14.4. Merck KgaA
14.5. Miltenyi Biotec
14.6. Thermo Fisher Scientific
14.7. Bio-Rad Laboratories Inc
14.8. Terumo BCT
14.9. PluriSelect Life Science UG & Co. KG
14.10. STEMCELL Technologies Inc (LIST NOT EXHAUSTIVE)
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us
